<DOC>
	<DOCNO>NCT00258128</DOCNO>
	<brief_summary>We believe diet induced obesity lead activation IKK/NF-kB inflamatory pathway chronic inflammation lead insulin resistance diabetes . In rodent , salicylate inhibit IKK/NF-kB may improve insulin sensitivity . We study true people .</brief_summary>
	<brief_title>Effect Salicylate Glucose Metabolism Insulin Resistance States</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>age 18 65 year , inclusive ; HbA1c &gt; 6.0 % ( medicationdiabetic ) normal hemoglobin hematocrit , without donation blood previous 2 month ; without involvement study evaluate investigational drug device previous 2 month ; normal clotting study ; female postmenopausal surgically sterile , use barrier oral contraception negative pregnancy test . pregnant lactating woman ; patient persistent ketonuria history ketoacidosis ( suggest need insulin therapy ) ; current previous use insulin glucose control ; patient abnormal liver function define elevation bilirubin , alkaline phosphatase , ALT , AST , GGTP 1.5 time upper limit normal ; patient kidney disease ( serum creatinine &gt; 1.5 mg/dL ) macroalbuminuria ( 1+ protein standard urine dipstick , &gt; 300 mg urinary albumin/day ) ( patient microalbuminuria enrol ) ; patient significant disease condition , include emotional psychiatric disorder substance abuse , include history binge drinking , , opinion investigator , likely alter patient 's ability complete study ; patient metabolic acidosis ( abnormal anion gap ) ; history gastric ulcer , dyspepsia , upper low GI bleed ; history allergy aspirin , bleed diathesis currently oral anticoagulant include warfarin , heparin , aspirin NSAIDs ; patient major vascular event within 6 month screen study ( e.g. , myocardial infarction stroke , coronary artery bypass graft ( CABG ) surgery , angioplasty , peripheral vascular surgery ) ; patient chronic heart disease , history myocardial infarction stroke . Symptomatic angina pectoris cardiac insufficiency define NYHA ; classification Functional Class III IV ; patient HbA1C &gt; 13 % ( normal range 46 % ) ; patient smoke one pack cigarettes daily ; patient take treatment medication know affect insulin sensitivity ( e.g . diuretic , betablockers ) ; patient take warfarin , heparin NSAID chronic basis ; patient inadequately control serum lipid level ( total cholesterol ≥ 275 mg/dL fast triglyceride ≥ 450 mg/dL ) ; patient history cancer within 5 year prior screen study basal cell carcinoma ; active alcohol substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>